(Albany, US) DelveInsight launched its new report on Vasomotor symptoms (Hot flashes/Night sweats)–Market Insights, Epidemiology and Market Forecast—2030
DelveInsight’s ‘Vasomotor symptoms (Hot flashes/Night sweats)–Market Insights, Epidemiology and Market Forecast—2030’ report delivers an in-depth understanding of the Vasomotor symptoms including Hot flashes or night sweats, historical and forecasted epidemiology as well as the Vasomotor symptoms (Hot flashes/Night sweats) market trends in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.
View report: https://www.delveinsight.com/sample-request/vasomotor-symptoms-market
Some of the key facts of the report: The United States has recorded the highest prevalent population of Hot Flashes associated with Post Menopause of 18,926,632 cases in 2017.
Key benefits of the report: 1. Vasomotor Symptoms market report covers a descriptive overview and comprehensive insight of the Vasomotor Symptoms epidemiology and Vasomotor Symptoms market in the 7 MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.) 2. Vasomotor Symptoms market report provides insights into the current and emerging therapies. 3. Vasomotor Symptoms market report provides a global historical and forecasted market covering drug outreach in 7 MM. 4. Vasomotor Symptoms market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Vasomotor Symptoms market.
“The total prevalent population of Vasomotor Symptoms associated with post menopause in 7MM countries was 41,096,968 in 2017.”
“Hot Flashes refer to the sudden sensation of extreme heat in the upper body, particularly the face, neck, and chest. The current therapeutic landscape of Hot Flashes Associated with menopause in the US can be divided into two major categories based on the class of drug. These are Hormonal Therapies and Nonhormonal Therapy.”
Request for sample pages: https://www.delveinsight.com/sample-request/vasomotor-symptoms-market
The key players in Vasomotor Symptoms market are: 1. Mithra Pharmaceuticals (Donesta Biosciences) 2. KaNDy Therapeutics 3. Fervent Pharmaceuticals 4. Astellas Pharma 5. Sojournix 6. Mitsubishi Tanabe Pharma
The launch of the emerging therapies is expected to significantly impact Vasomotor Symptoms treatment scenario in the upcoming years:-
Drugs covered 1. Donesta 2. NT-814 3. FP-101 4. Fezolinetant 5. SJX 653 6. MT-8554
Table of contents 1. Key Insights 2. Vasomotor Symptoms Market Overview at a Glance 3. Executive summary 4. Organizations 5. Vasomotor Symptoms Epidemiology and Market Methodology 6. Vasomotor Symptoms associated with menopause Disease Background and Overview 7. Vasomotor Symptoms Epidemiology and Patient Population 8. Total Vasomotor Symptoms in Post-menopause Prevalent cases in 7MM 9. Country Wise Hot Flashes Associated with Post-menopause Epidemiology 9.1. United States 9.2. EU5 Countries 9.3. Germany 9.4. France 9.5. Italy 9.6. Spain 9.7. United Kingdom 9.8. Japan 10. Vasomotor Symptoms Treatment Algorithm, Current Treatment, and Medical Practices 11. Unmet Needs 12. Vasomotor Symptoms Marketed drugs by class 12.1. Hormonal Therapies 12.2. Non-hormonal Therapies 12.3. Recent additions in Hormonal therapies 12.4. Bijuva: TherapeuticsMD 13. Vasomotor Symptoms Emerging Therapies 13.1. Key Cross Competition 13.2. Hormonal Based therapies 13.3. Donesta: Mithra Pharmaceuticals (Donesta Biosciences) 13.4. Non-Hormonal Based therapies 13.5. NT-814: KaNDy Therapeutics 13.6. FP-101: Fervent Pharmaceuticals 13.7. Fezolinetant: Astellas Pharma 13.8. Other Potential therapies 13.9. SJX 653: Sojournix 13.10. MT-8554: Mitsubishi Tanabe Pharma 14. Hot Flashes 7 Major Market Analysis 15. Seven Major Market Outlook 15.1. United States Market Size 15.2. Germany 15.3. France 15.4. Italy 15.5. Spain 15.6. United Kingdom 15.7. Japan 16. Market Drivers 17. Market Barriers 18. SWOT 19. Case Studies 20. KOL Views 21. Appendix 22. DelveInsight Capabilities 23. Disclaimer 24. About DelveInsight
Related reports:
Vasomotor symptoms (Hot flashes/Night sweats)– Epidemiology Forecast—2030
Vasomotor Symptoms of Menopause Pipeline Insight, 2020
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Kritika RehaniEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/